TP53 and cancer: Reactivating p53 mutant to wild type tumor-suppressive function was possible in cancer cells (e.g. SK-BR-3 cells) using other types of isothiocyanates (e.g. phenethyl isothiocyanate PEITC) both in vitro and in vivo.